Eli Lilly & Co. (LLY)
NYSE · Common stock · Pharmaceutical Preparations
As of Oct 21, 2:16 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow LLY in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on LLY and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
LLY at a glance
Key statistics
$1.14T
Market capitalization
- Previous close
- $1,283.66
- Open
- $1,267.04
- Day range
- $1,262.86 – $1,278.42
- Volume
- 987.5K
- Average volume (30 sessions)
- 2.29M
- Shares outstanding
- 941.36M
- Price / earnings
- 42.8
- Earnings per share
- $29.97
- Price / book
- 33.8
- Price / sales
- 14.4
- Dividend yield
- 0.51%
- Beta (1 year, vs SPY)
- 0.25
Where the price sits in its year
52-week range
92% of the range
- Below the 52-week high
- -3.1%
- Above the 52-week low
- +60.0%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $1,188.21+8.0%
- 50-day average
- $1,182.47+8.6%
- 200-day average
- $1,081.75+18.7%
Between the conventional 30 and 70 bands.
+10.0%
1 week
+10.2%
1 month
+10.4%
3 months
+19.4%
Year to date
+59.9%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with LLY
LLY on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on LLY.
See the plans →
Every planScreen names like LLY
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on LLY
Put LLY on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on LLY
See whether there is an open premium alert on LLY, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
LLY headlines
No headlines on the wire for LLY in recent weeks.
SEC Form 4, most recent first
Insider filings
Sulzberger Gabrielle
+3.998
Director · Grant or award
$4.96K · Oct 19, 2026
Alvarez Ralph
+10.011
Director · Grant or award
$12.42K · Oct 19, 2026
Fyrwald J Erik
+7.995
Director · Grant or award
$9.92K · Oct 19, 2026
LUCIANO JUAN R
+12.833
Director · Grant or award
$15.92K · Oct 19, 2026
Sulzberger Gabrielle
+4.257
Director · Grant or award
$4.96K · Sep 21, 2026
LUCIANO JUAN R
+13.664
Director · Grant or award
$15.92K · Sep 21, 2026
Fyrwald J Erik
+8.513
Director · Grant or award
$9.92K · Sep 21, 2026
Alvarez Ralph
+10.659
Director · Grant or award
$12.42K · Sep 21, 2026
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
- Exchange
- NYSE
- Security
- Common stock
- Industry
- Pharmaceutical Preparations
- Headquarters
- Indianapolis, IN
- Employees
- 50,000
- Listed since
- Jul 9, 1970
- Website
- lilly.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.